Status and phase
Conditions
Treatments
About
The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC)
Eligible for CRRC discharge:
For DM patients:
For Non-DM patients:
Able and willing to sign informed consent.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal